Enrollment Surpasses Projections in International Psoriasis Studies
Case Study
Mar 04, 2019
A leading global pharmaceutical company selected IQVIA Biotech to support four large, international Phase III biologic studies in moderate to severe psoriasis. The IQVIA Biotech dermatology team was selected because of a proven patient recruitment process with a record of enrollment that could save the sponsor time and money. Successful patient recruitment strategies in 13 countries, where some are unfamiliar with advertising, surpassed enrollment projections.